Revision of amino acid replacement reported in FBrf0135684.
Amino acid replacement: R460term.
C24132164T
C?T|FBrf0135684
R460term | Tsc1-PA
R460term
Site of nucleic acid difference inferred by FlyBase based on reported amino acid change
Tsc1R453X/Tsc1R453X mutants do not exhibit defective learning in an aversive conditioning assay, but do exhibit defects in a reversal-learning paradigm, with a third-odor preference assay showing an inability to forget the first aversive odor association after training with a second aversive odor, as compared to wild type flies.
Tsc1R453X homozygous intestinal stem cell (ISC) clones are lost over time. In wild-type clones, approximately 86-100% of ISC clones present on day 4 are maintained on day 14, while almost all Tsc1R453X homozygous clones present on day 4 are absent on day 14. The remaining ISC clones on day 14 generally contain fewer cells, indicating that the Tsc1R453X clones are under-proliferative. The mutant ISCs are also larger than in wild-type. The distribution of TUNEL, a marker for fragmented DNA, indicative of apoptosis, shows that Tsc1R453X mutant ISC clones do not undergo apoptosis.
Tsc1R453X homozygous intestinal stem cell (ISC) clones from flies fed on a restricted diet are lost at a similar rate as in wild-type clones. Tsc1R453X homozygous intestinal stem cell (ISC) clones grow significantly larger regardless of nutritional status.
Tsc1R453X mutant eye disc clones undergo apoptosis just anterior to the morphogenetic furrow.
Homozygous clones in the eye disc result in robust overgrowth of the eye.
Tsc1R453X mutants show no defects in opsin regulation.
Tsc1R453X has increased cell death | somatic clone phenotype, enhanceable by Rbf120a
Rbf120a, Tsc1R453X has increased cell death | somatic clone phenotype, suppressible by Rheb2D1
Tsc1R453X has hyperplasia | somatic clone phenotype, non-suppressible by rictorΔ2
Tsc1R453X is an enhancer of increased cell death | somatic clone phenotype of Rbf120a
Tsc1R453X is an enhancer of increased occurrence of cell division | larval stage | somatic clone phenotype of Rbf120a
Tsc1R453X has eye disc | somatic clone phenotype, enhanceable by Rbf120a
Tsc1R453X has eye disc morphogenetic furrow | somatic clone phenotype, enhanceable by Rbf120a
Rbf120a, Tsc1R453X has eye disc | somatic clone phenotype, suppressible by Rheb2D1
Rbf120a, Tsc1R453X has eye disc morphogenetic furrow | somatic clone phenotype, suppressible by Rheb2D1
Tsc1R453X has eye | somatic clone phenotype, non-suppressible by rictorΔ2
Tsc1R453X is an enhancer of eye disc anterior to the morphogenetic furrow | somatic clone phenotype of Rbf120a
Tsc1R453X is an enhancer of eye disc morphogenetic furrow | somatic clone phenotype of Rbf120a
Rbf120a Tsc1R453X double mutant eye disc clones exhibit ectopic S-phase cells at the morphogenetic furrow. Approximately 12.4 ectopic S-phase cells/pixels are present in Rbf120a Tsc1R453X double mutant eye disc clones, showing a 3-fold increase compared to Rbf120a single mutant clones.
The ectopic cell death observed in Rbf120a Tsc1R453X double mutant cells is completely suppressed in Rheb2D1 mutant clones.
Rbf120a Tsc1R453X double mutant eye disc clones exhibit a large increase in apoptosis at the morphogenetic furrow and the anterior region of the eye disc.
"Amino acid replacement: R460@." was stated as revision.